NZ719000A - Slow-release solid oral compositions - Google Patents
Slow-release solid oral compositionsInfo
- Publication number
- NZ719000A NZ719000A NZ719000A NZ71900014A NZ719000A NZ 719000 A NZ719000 A NZ 719000A NZ 719000 A NZ719000 A NZ 719000A NZ 71900014 A NZ71900014 A NZ 71900014A NZ 719000 A NZ719000 A NZ 719000A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutically acceptable
- solid oral
- slow
- release solid
- oral compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001906A ITMI20131906A1 (it) | 2013-11-18 | 2013-11-18 | Composizioni solide orali a lento rilascio |
| US201461989645P | 2014-05-07 | 2014-05-07 | |
| PCT/IB2014/065852 WO2015071806A1 (en) | 2013-11-18 | 2014-11-06 | Slow-release solid oral compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ719000A true NZ719000A (en) | 2017-06-30 |
Family
ID=49780196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ719000A NZ719000A (en) | 2013-11-18 | 2014-11-06 | Slow-release solid oral compositions |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10702482B2 (https=) |
| EP (1) | EP3071191B1 (https=) |
| JP (1) | JP6401270B2 (https=) |
| KR (1) | KR102224087B1 (https=) |
| CN (1) | CN105764493B (https=) |
| AU (1) | AU2014349782B2 (https=) |
| BR (1) | BR112016011142B1 (https=) |
| CA (1) | CA2929426C (https=) |
| DK (1) | DK3071191T3 (https=) |
| EA (1) | EA039558B1 (https=) |
| ES (1) | ES2908924T3 (https=) |
| GE (2) | GEP20186884B (https=) |
| HR (1) | HRP20220271T1 (https=) |
| HU (1) | HUE058086T2 (https=) |
| IL (1) | IL245167B (https=) |
| IT (1) | ITMI20131906A1 (https=) |
| LT (1) | LT3071191T (https=) |
| MX (1) | MX367664B (https=) |
| NZ (1) | NZ719000A (https=) |
| PH (1) | PH12016500693A1 (https=) |
| PL (1) | PL3071191T3 (https=) |
| PT (1) | PT3071191T (https=) |
| RS (1) | RS62916B1 (https=) |
| UA (1) | UA119856C2 (https=) |
| WO (1) | WO2015071806A1 (https=) |
| ZA (1) | ZA201602659B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700074957A1 (it) * | 2017-07-04 | 2019-01-04 | Gnosis Spa | Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo |
| CN109939077B (zh) * | 2017-12-04 | 2022-07-22 | 深圳奥萨制药有限公司 | 一种含有5-甲基四氢叶酸的控释制剂 |
| CN111990674B (zh) * | 2020-01-14 | 2021-07-02 | 青岛圣邦健康食品有限公司 | 肠溶包衣材料及其制备方法和肠溶制品 |
| IT202000006127A1 (it) * | 2020-03-23 | 2021-09-23 | Fmc S R L | Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione |
| IT202300007692A1 (it) * | 2023-04-19 | 2024-10-19 | Vifra S R L | Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1200589B (it) * | 1985-02-14 | 1989-01-27 | Gibipharma Spa | Derivati naturali attivita farmagologica |
| ITMI20012462A1 (it) * | 2001-11-22 | 2003-05-22 | Gnosis Srl | Processo per la preparazione di compresse comprendenti s-adenosilmetionina |
| US20050181047A1 (en) * | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements |
| EP1809255A4 (en) * | 2004-11-05 | 2011-08-03 | Fabre Kramer Holdings Inc | HIGH DOSAGE FORMULATION OF GEPIRON WITH EXTENDED RELEASE |
| ITMI20060629A1 (it) * | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| US20090088404A1 (en) | 2007-01-31 | 2009-04-02 | Methylation Sciences International Srl | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| KR20070093972A (ko) * | 2007-06-05 | 2007-09-19 | 파브르-크래머 홀딩스. 인크 | 게피론의 고용량 서방성 제제 |
| US7947662B2 (en) * | 2008-02-20 | 2011-05-24 | Gnosis S.P.A. | Folates, compositions and uses thereof |
| US8329208B2 (en) | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| US20110027342A1 (en) | 2009-07-28 | 2011-02-03 | Msi Methylation Sciences, Inc. | S-adenosylmethionine formulations with enhanced bioavailability |
| IT1401146B1 (it) * | 2010-07-27 | 2013-07-12 | Gnosis Spa | Composizione comprendente shellac e/o un suo sale e sodio amido glicolato |
-
2013
- 2013-11-18 IT IT001906A patent/ITMI20131906A1/it unknown
-
2014
- 2014-11-06 DK DK14812619.6T patent/DK3071191T3/da active
- 2014-11-06 PL PL14812619T patent/PL3071191T3/pl unknown
- 2014-11-06 AU AU2014349782A patent/AU2014349782B2/en active Active
- 2014-11-06 CN CN201480062634.8A patent/CN105764493B/zh active Active
- 2014-11-06 ES ES14812619T patent/ES2908924T3/es active Active
- 2014-11-06 CA CA2929426A patent/CA2929426C/en active Active
- 2014-11-06 HU HUE14812619A patent/HUE058086T2/hu unknown
- 2014-11-06 RS RS20220156A patent/RS62916B1/sr unknown
- 2014-11-06 PT PT148126196T patent/PT3071191T/pt unknown
- 2014-11-06 KR KR1020167011680A patent/KR102224087B1/ko active Active
- 2014-11-06 WO PCT/IB2014/065852 patent/WO2015071806A1/en not_active Ceased
- 2014-11-06 GE GEAP201414177A patent/GEP20186884B/en unknown
- 2014-11-06 JP JP2016532105A patent/JP6401270B2/ja active Active
- 2014-11-06 GE GEAP201814177A patent/GEAP201814177A/en unknown
- 2014-11-06 MX MX2016006442A patent/MX367664B/es active IP Right Grant
- 2014-11-06 US US15/037,149 patent/US10702482B2/en active Active
- 2014-11-06 LT LTEPPCT/IB2014/065852T patent/LT3071191T/lt unknown
- 2014-11-06 EP EP14812619.6A patent/EP3071191B1/en active Active
- 2014-11-06 EA EA201691034A patent/EA039558B1/ru unknown
- 2014-11-06 HR HRP20220271TT patent/HRP20220271T1/hr unknown
- 2014-11-06 UA UAA201605352A patent/UA119856C2/uk unknown
- 2014-11-06 NZ NZ719000A patent/NZ719000A/en unknown
- 2014-11-06 BR BR112016011142-7A patent/BR112016011142B1/pt active IP Right Grant
-
2016
- 2016-04-14 PH PH12016500693A patent/PH12016500693A1/en unknown
- 2016-04-17 IL IL245167A patent/IL245167B/en active IP Right Grant
- 2016-04-19 ZA ZA2016/02659A patent/ZA201602659B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012174158A3 (en) | Administration of benzodiazepine | |
| IL223795A (en) | History of Tetrahydro-Pyrido-Pyrimidine | |
| IL222578A0 (en) | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same | |
| WO2011104652A3 (en) | Veterinary compositions | |
| PH12016500693A1 (en) | Slow-release solid oral compositions | |
| MX383492B (es) | Comprimidos probióticos bicapa de doble liberación. | |
| WO2011101863A3 (en) | Extended release pharmaceutical compositions of lacosamide | |
| PL3003285T3 (pl) | Stała farmaceutyczna postać dawkowania do uwalniania co najmniej dwóch substancji czynnych w jamie ustnej | |
| PL2557943T3 (pl) | Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki | |
| HK1208222A1 (en) | Modified release formulations for oprozomib | |
| HUE040666T2 (hu) | Ibandronsavat vagy gyógyászatilag elfogadható sóját és D vitamint tartalmazó, orális beadásra alkalmas szilárd kompozíció | |
| MX387731B (es) | Composiciones farmacéuticas orales de mesalazina. | |
| IL280083A (en) | A pharmaceutical dosage form that can be administered orally and with a modified release | |
| WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
| EP3290037A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| IL213671A (en) | Pharmaceutical preparations containing alglitazar, a process for their preparation and use for the preparation of medicines | |
| WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
| EP3381467A4 (en) | PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING A PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION | |
| IL236562A0 (en) | A pharmaceutical preparation with an improved flow capacity, a medical agent, and a method for its production and use | |
| MX2015015681A (es) | Composicion farmaceutica que comprende fingolimod. | |
| EP2575457A4 (en) | ORAL PHARMACEUTICAL DULOXETIN COMPOSITION | |
| EP3065737A4 (en) | Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form | |
| MX340846B (es) | Composición de nitazoxanida mejorada y proceso para prepararla. | |
| EP2529755A4 (en) | PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION | |
| PH12018550075A1 (en) | An oral osmotic pharmaceutical composition of vildagliptin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2019 BY COMPUTER PACKAGES INC Effective date: 20181018 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2020 BY COMPUTER PACKAGES INC Effective date: 20191018 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2021 BY COMPUTER PACKAGES INC Effective date: 20201020 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2022 BY COMPUTER PACKAGES INC Effective date: 20211017 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2023 BY COMPUTER PACKAGES INC Effective date: 20221017 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2024 BY COMPUTER PACKAGES INC Effective date: 20231017 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2025 BY COMPUTER PACKAGES INC Effective date: 20241017 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 NOV 2026 BY COMPUTER PACKAGES INC Effective date: 20251017 |